CoreAge Rx’s TRT page now advertises compounded injectable testosterone beginning at $129 per month. Hone Health presents care through memberships with medication billed separately. These are different ways of describing a potential purchase, so the monthly numbers need context.
CoreAge’s primary action currently says Coming soon. Its first promotional placement on TRT Papi does not change that status or establish clinical superiority. This comparison uses published information to prepare a more useful conversation about access, assessment, and total costs.
KEEP IN MIND
A few things to remember.
- CoreAge lists a starting product price but currently displays Coming soon.
- Hone’s membership prices exclude medication and have different service scopes.
- Ask for the complete assessment, prescription, and follow-up proposal.
Ask whether the pathway is available to you
CoreAge’s verified product page names a medicine and outlines testing and virtual review. It does not yet establish an active TRT enrollment route from the visible Coming soon control. Request confirmation of opening and state coverage before treating it as an appointment you can book immediately.
Hone’s site presents a starting biomarker test and consultation at $65. Confirm that the assessment matches the concern you want evaluated and is available in your location. A marketed starting pathway is not a guarantee of a particular diagnosis, prescription, or clinician recommendation.
Sources: CoreAge Rx: injectable TRT product page and Coming soon status · Hone Health: Basic and Premium memberships and starting assessment
Keep membership and medication on different lines
Hone advertises Basic at $25 monthly and Premium at $155 monthly, with medication charges additional. Its Basic description includes testing and the option to purchase consultations; Premium describes clinician consultations and recurring follow-up. The $25 price should not be presented as a complete testosterone treatment package.
CoreAge’s starting figure is attached to its injectable product listing, with no-membership-fee language. The full lab, supply-period, and continuing-care costs still need confirmation. Ask both companies for required components over the same period before deciding which proposed plan costs less.
Sources: Hone Health: Basic and Premium memberships and starting assessment · CoreAge Rx: injectable TRT product page and Coming soon status
Make the first laboratory visit understandable
CoreAge mentions home or in-person blood collection, with Quest named in its TRT FAQ. Ask which arrangement applies to your address and whether it is included in the advertised amount. Our CoreAge lab guide explains the panel and existing-record questions that remain open.
Hone advertises testing within its care structure, but a reader still needs instructions for the actual order and a plan for reviewing results. Ask how prior reports are used and whether further testing changes the cost. Completing a broad panel does not by itself prove that testosterone replacement is appropriate.
Sources: CoreAge Rx: injectable TRT product page and Coming soon status · Hone Health: Basic and Premium memberships and starting assessment
Know which medicine the clinician is considering
CoreAge’s listing identifies compounded testosterone cypionate. A compounded preparation is not FDA-approved, even though approved testosterone products exist. Request the dispensing pharmacy and complete product details if a prescription is proposed. A displayed concentration must not be interpreted as your dose.
With Hone, ask for the same medicine-specific details rather than assuming that a membership identifies a single formulation. Clinical evaluation should consider symptoms, reliable testing, medical history, and the reasons for treatment. Neither provider’s wellness language determines the prescription appropriate to an individual.
Sources: CoreAge Rx: injectable TRT product page and Coming soon status · FDA: understanding the risks of compounded drugs · Endocrine Society: testosterone therapy clinical guidance
Compare continuing responsibilities and financial terms
Hone’s Premium description includes periodic retesting and follow-ups, with medication still additional. CoreAge’s product page discusses ongoing support without specifying every clinical interval. Request the prescriber contact, monitoring schedule, refill process, and what happens when more evaluation is needed.
CoreAge’s general FAQ and refund policy differ on renewals and refunds, so its applicable agreement needs a direct answer. Read the CoreAge review and Hone review for the wider context. A decision should rest on confirmed access and a complete clinical and financial proposal, rather than a comparison of unlike headline prices.
Sources: CoreAge Rx: refund, subscription, and shipping policy · CoreAge Rx: general service, billing, and pharmacy FAQ · Hone Health: Basic and Premium memberships and starting assessment
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Source review: September 27, 2026. Prices and availability can change.
- CoreAge Rx: injectable TRT product page and Coming soon status
- Hone Health: Basic and Premium memberships and starting assessment
- FDA: understanding the risks of compounded drugs
- Endocrine Society: testosterone therapy clinical guidance
- CoreAge Rx: refund, subscription, and shipping policy
- CoreAge Rx: general service, billing, and pharmacy FAQ
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.